Alembic Of India Plans Focus Switch From Local Market To Europe, U.S.
This article was originally published in PharmAsia News
Executive Summary
India's Alembic Pharma plans to shift from producing active pharmaceutical ingredients for the local market to focus on Europe and the United States, which it believes offer greater profitability.